Sanofi to snap up Blueprint Medicines and mastocytosis drug Ayvakit for $9.1B

endpoints.news/sanofi-to-snap-up-blueprint-medicines-and-mastocytosis-drug-ayvakit-for-9-1b

Kate Haviland, Blueprint Medicines CEO
Sanofi to snap up Blueprint Medicines and mastocytosis drug Ayvakit for $9.1B
In the biggest biopharma deal since January, Sanofi is bolstering its rare immunology offering by acquiring Blueprint Medicines for $9.1 billion.
The French drugmaker has …

This story appeared on endpoints.news, 2025-06-02 17:37:06.747000.
The Entire Business World on a Single Page. Free to Use →